Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Considerations for using lower doses of warfarin.

M M Bern1

  • 1Cancer Center of Boston, Massachusetts.

Hematology/Oncology Clinics of North America
|October 1, 1992
PubMed
Summary

Lower warfarin doses are effective anticoagulants, reducing hemorrhagic risk. Further research is needed to determine the lowest effective dose and appropriate clinical settings for reduced warfarin therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of anticoagulation on markers of activation of clotting following major orthopedic surgery.

International journal of laboratory hematology·2015
Same author

Autologous blood donation and subsequent blood use in patients undergoing total knee arthroplasty.

Transfusion medicine (Oxford, England)·2006
Same author

Treatment of factor XI inhibitor using recombinant activated factor VIIa.

Haemophilia : the official journal of the World Federation of Hemophilia·2005
Same author

Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas.

Cancer·1999
Same author

Pilot study of ambulatory infusional ifosfamide admixed with carboplatin.

Cancer·1993
Same author

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.

Annals of internal medicine·1990

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Thrombosis Research

Background:

  • Warfarin is a widely used anticoagulant.
  • Standard warfarin dosing is ambiguous due to thromboplastin variability.
  • Full anticoagulation doses carry a risk of hemorrhage.

Purpose of the Study:

  • To investigate the efficacy of reduced warfarin doses.
  • To determine the lowest effective warfarin dose.
  • To identify clinical settings for lower-dose warfarin use.

Main Methods:

  • Review of existing literature on warfarin dosing.
  • Analysis of prothrombin time measurements and thromboplastin variations.
  • Clinical data assessment for warfarin efficacy and safety.

Main Results:

  • Lower warfarin doses demonstrate efficacy in anticoagulation.
  • Reduced doses significantly mitigate hemorrhagic risks associated with standard therapy.
  • The precise threshold for minimal effective dosing requires further investigation.

Conclusions:

  • Reduced warfarin dosing is a viable strategy for safe anticoagulation.
  • Establishing optimal low-dose regimens requires cautious clinical validation.
  • Further studies are essential to define specific clinical applications for dose reduction.

Related Experiment Videos